ZYTIGA® (abiraterone acetate) & PREDNISONE
STRONG TOGETHER
LET’S DO THIS
METASTATIC HIGH-RISK CSPC EFFICACY & SAFETY
- LATITUDE Study Final Analysis
- Efficacy endpoints
- Safety Profile
CSPC = Castration-Sensitive Prostate Cancer
METASTATIC CRPC EFFICACY & SAFETY
- Final analysis for COU-AA-302 and COU-AA-301 studies
- Co-primary and secondary endpoint data
- Established safety and tolerability profile
- Discontinuation criteria
CRPC = Castration-Resistant Prostate Cancer
DOSING & MONITORING
- Recommended dosage and administration
- Dose modification guidelines
- Patient monitoring considerations and schedule
OR
RESOURCES
- Comprehensive access support for your patients
- Identifying cost support options
- Helpful answers to common questions about ZYTIGA®